Lista de obras - Johan Mouton - Dominio Público Uruguay

A Novel Y319H Substitution in CYP51C Associated with Azole Resistance in Aspergillus flavus.

artículo científico publicado en 2015

A long journey from minimum inhibitory concentration testing to clinically predictive breakpoints: deterministic and probabilistic approaches in deriving breakpoints.

artículo científico publicado en 2009

A retrospective analysis using Monte Carlo simulation to evaluate recommended ceftazidime dosing regimens in healthy volunteers, patients with cystic fibrosis, and patients in the intensive care unit

artículo científico publicado en 2005

A role for TLR1, TLR2 and NOD2 in cytokine induction by Bacteroides fragilis.

artículo científico publicado en 2012

A structural comparison of lipopolysaccharide biosynthesis loci of Legionella pneumophila serogroup 1 strains

artículo científico publicado en 2013

Aerosol therapy in cystic fibrosis: a survey of 54 CF centers

artículo científico publicado en 2000

Amikacin Pharmacokinetics/Pharmacodynamics in a Novel Hollow-Fiber Mycobacterium abscessus Disease Model

artículo científico publicado en 2015

Amoxicillin pharmacokinetics in pregnant women with preterm premature rupture of the membranes

artículo científico publicado en 2007

Applying pharmacokinetic/pharmacodynamic principles in critically ill patients: optimizing efficacy and reducing resistance development

artículo científico publicado en 2015

Assessing in vitro combinations of antifungal drugs against yeasts and filamentous fungi: comparison of different drug interaction models.

artículo científico publicado en 2005

Assessment of bactericidal drug activity and treatment outcome in a mouse tuberculosis model using a clinical Beijing strain

artículo científico publicado en 2017

Assessment of efficacy of antifungals in experimental models of invasive aspergillosis in an era of emerging resistance: the value of real-time quantitative PCR.

artículo científico publicado en 2011

Azole-resistant Aspergillus fumigatus, Iran.

artículo científico publicado en 2013

Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink?

artículo científico publicado en 2010

Chlamydia antibody testing and diagnosing tubal pathology in subfertile women: an individual patient data meta-analysis

artículo científico publicado en 2011

Ciprofloxacin in preterm neonates: case report and review of the literature.

artículo científico publicado en 1998

Clinical Impact of Preincubation of Blood Cultures at 37°C ⬇️

artículo científico publicado el 10 de noviembre de 2010

Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin

artículo científico publicado en 2015

Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial

artículo científico publicado en 2018

Colistin versus colistin plus meropenem for severe infections Authors' reply.

artículo científico publicado en 2018

Colonization and infection by Serratia species in a paediatric surgical intensive care unit

artículo científico publicado en 2001

Combination of pantothenamides with vanin inhibitors as a novel antibiotic strategy against gram-positive bacteria.

artículo científico publicado en 2013

Comparison of the Etest and the sensititre colorimetric methods with the NCCLS proposed standard for antifungal susceptibility testing of Aspergillus species

artículo científico publicado en 2002

Composite survival index to compare virulence changes in azole-resistant Aspergillus fumigatus clinical isolates

artículo científico publicado en 2013

Conserving antibiotics for the future: New ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective ⬇️

artículo científico publicado el 26 de marzo de 2011

Consistent Global Approach on Reporting of Colistin Doses to Promote Safe and Effective Use

artículo científico publicado en 2013

Consumption of antimicrobials in pigs, veal calves, and broilers in the Netherlands: quantitative results of nationwide collection of data in 2011.

artículo científico publicado en 2013

Continuous infusion of beta-lactams.

artículo científico publicado en 2007

Correlation of MIC value and disk inhibition zone diameters in clinical Legionella pneumophila serogroup 1 isolates

artículo científico publicado en 2013

Correlation of the MIC and dose/MIC ratio of fluconazole to the therapeutic response of patients with mucosal candidiasis and candidemia

artículo científico publicado en 2007

Decreased ciprofloxacin susceptibility in Salmonella Typhi and Paratyphi infections in ill-returned travellers: the impact on clinical outcome and future treatment options.

artículo científico publicado en 2013

Different demographic and sexual correlates for chlamydial infection and gonorrhoea in Rotterdam.

scientific article published on December 1997

Dose-response relationships of three amphotericin B formulations in a non-neutropenic murine model of invasive aspergillosis.

artículo científico publicado en 2009

EUCAST testing of Isavuconazole susceptibility in Aspergillus: comparison of results for Inoculum standardization using Conidium counting versus optical density.

artículo científico publicado en 2014

Efficacy and pharmacodynamics of voriconazole combined with anidulafungin in azole-resistant invasive aspergillosis

artículo científico publicado en 2012

Efficacy of antifungal therapy in a nonneutropenic murine model of zygomycosis

artículo científico publicado en 2002

Exchange of Pseudomonas aeruginosa strains among cystic fibrosis siblings

scientific article published on 01 June 1997

Experience with a once-daily dosing program of aminoglycosides in critically ill patients

artículo científico publicado en 2002

Exposure-Response Relationships for Isavuconazole in Patients with Invasive Aspergillosis and Other Filamentous Fungi.

artículo científico publicado en 2017

Extensive genetic diversity within the Dutch clinical Cryptococcus neoformans population

artículo científico publicado en 2012

Failure of posaconazole therapy in a renal transplant patient with invasive aspergillosis due to Aspergillus fumigatus with attenuated susceptibility to posaconazole ⬇️

artículo científico publicado en 2011

Failure of the Amikacin, Cefoxitin, and Clarithromycin Combination Regimen for Treating Pulmonary Mycobacterium abscessus Infection

artículo científico publicado en 2016

Forgotten antibiotics: an inventory in Europe, the United States, Canada, and Australia

artículo científico publicado en 2012

Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus

artículo científico publicado en 2014

Impact of pharmacodynamics on breakpoint selection for susceptibility testing

artículo científico publicado en 2003

In Vitro Activity of Ceftolozane Alone and in Combination with Tazobactam against Extended-Spectrum-β-Lactamase-Harboring Enterobacteriaceae.

artículo científico publicado en 2015

In Vitro Antifungal Susceptibility Testing of Candida Isolates with the EUCAST Methodology, a New Method for ECOFF Determination.

artículo científico publicado en 2017

In memoriam: William A. Craig.

artículo científico publicado en 2015

In vitro activities at pH 5.0 and pH 7.0 and in vivo efficacy of flucytosine against Aspergillus fumigatus.

artículo científico publicado en 2008

In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates

artículo científico publicado en 2002

In vitro activities of pentamidine, pyrimethamine, trimethoprim, and sulfonamides against Aspergillus species

artículo científico publicado en 2002

In vitro activity of ceftazidime-avibactam combination in in vitro checkerboard assays

artículo científico publicado en 2014

In vitro activity of isavuconazole against 208 Aspergillus flavus isolates in comparison with 7 other antifungal agents: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing.

artículo científico publicado en 2011

In vitro interaction of voriconazole and anidulafungin against triazole-resistant Aspergillus fumigatus.

artículo científico publicado en 2012

In vitro susceptibilities of zygomycetes to conventional and new antifungals

artículo científico publicado en 2003

In-vitro activity of quinupristin/dalfopristin compared with other widely used antibiotics against strains isolated from patients with endocarditis ⬇️

artículo científico publicado el 1 de mayo de 1997

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions

artículo científico publicado en 2014

Inhibitory and fungicidal effects of antifungal drugs against Aspergillus species in the presence of serum

artículo científico publicado en 2013

International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of Americ

scientific article published on 01 January 2019

Invasive Aspergillosis by Aspergillus flavus: Epidemiology, Diagnosis, Antifungal Resistance, and Management

scientific article published on 01 July 2019

Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs.

artículo científico publicado en 2017

Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs.

artículo científico publicado en 2017

Lung overinflation without positive end-expiratory pressure promotes bacteremia after experimental Klebsiella pneumoniae inoculation ⬇️

artículo científico publicado el 1 de febrero de 1998

Molecular epidemiology of Staphylococcus aureus strains colonizing the lungs of related and unrelated cystic fibrosis patients

scientific article published on 01 April 1997

Moxifloxacin's Limited Efficacy in the Hollow-Fiber Model of Mycobacterium abscessus Disease

artículo científico publicado en 2016

Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): a study protocol

artículo científico publicado en 2016

New dosing strategies for antibacterial agents in the neonate

artículo científico publicado en 2004

Optimal exposures of ceftazidime predict the probability of microbiological and clinical outcome in the treatment of nosocomial pneumonia

artículo científico publicado en 2012

Oral Fosfomycin Efficacy with Variable Urinary Exposures following Single and Multiple Doses against Enterobacterales: the Importance of Heteroresistance for Growth Outcome

scientific article published on 21 February 2020

Oral Fosfomycin Treatment for Enterococcal Urinary Tract Infections in a Dynamic In Vitro Model

artículo científico publicado en 2020

Pharmacodynamics and dose-response relationships of liposomal amphotericin B against different azole-resistant Aspergillus fumigatus isolates in a murine model of disseminated aspergillosis

artículo científico publicado en 2013

Pharmacodynamics of Cefepime Combined with Tazobactam against Clinically Relevant Enterobacteriaceae in a Neutropenic Mouse Thigh Model

artículo científico publicado en 2017

Pharmacodynamics of Ceftazidime and Avibactam in Neutropenic Mice with Thigh or Lung Infection

artículo científico publicado en 2015

Pharmacodynamics of Ceftolozane Combined with Tazobactam against Enterobacteriaceae in a Neutropenic Mouse Thigh Model

scientific article published on 26 September 2016

Pharmacodynamics of Voriconazole against Wild-Type and Azole-Resistant Aspergillus flavus Isolates in a Nonneutropenic Murine Model of Disseminated Aspergillosis

artículo científico publicado en 2016

Pharmacodynamics of anidulafungin against clinical Aspergillus fumigatus isolates in a nonneutropenic murine model of disseminated aspergillosis.

artículo científico publicado en 2012

Pharmacodynamics of imipenem in combination with β-lactamase inhibitor MK7655 in a murine thigh model

artículo científico publicado en 2014

Pharmacodynamics of isavuconazole in an Aspergillus fumigatus mouse infection model

artículo científico publicado en 2015

Pharmacokinetic/pharmacodynamic modelling of antibacterials in vitro and in vivo using bacterial growth and kill kinetics: the minimum inhibitory concentration versus stationary concentration.

artículo científico publicado en 2005

Pharmacokinetics and Pharmacodynamics of Murepavadin in Neutropenic Mouse Models

artículo científico publicado en 2019

Pharmacokinetics and penetration of ceftazidime and avibactam into epithelial lining fluid in thigh- and lung-infected mice

artículo científico publicado en 2015

Pharmacokinetics of meropenem in serum and suction blister fluid during continuous and intermittent infusion ⬇️

artículo científico publicado el 1 de diciembre de 1991

Population pharmacokinetics of vancomycin in obesity: Finding the optimal dose for (morbidly) obese individuals

scientific article published on 07 January 2020

Posaconazole prophylaxis in experimental azole-resistant invasive pulmonary aspergillosis.

artículo científico publicado en 2014

Prevention of invasive aspergillosis in AIDS by sulfamethoxazole.

artículo científico publicado en 2001

Protein Binding: Do We Ever Learn? ⬇️

artículo científico publicado el 2 de mayo de 2011

Rapid and reliable identification of Streptococcus anginosus group isolates to the species level by real-time PCR and melting curve analysis.

artículo científico publicado en 2008

Relationship between pharmacodynamic indices and killing patterns in vitro.

artículo científico publicado en 2011

Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria

artículo científico

Resistance of Asian Cryptococcus neoformans serotype A is confined to few microsatellite genotypes

artículo científico publicado en 2012

Serum concentrations of cefotaxime and its metabolite desacetyl-cefotaxime in infants and children during continuous infusion

artículo científico publicado en 2008

Synergistic activity of rifampicin and ethambutol against slow-growing nontuberculous mycobacteria is currently of questionable clinical significance

scholarly article by Jakko van Ingen et al published July 2013 in International Journal of Antimicrobial Agents

The influence of labour on the pharmacokinetics of intravenously administered amoxicillin in pregnant women

artículo científico publicado en 2008

The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment

artículo científico publicado en 2012

The strength of synergistic interaction between posaconazole and caspofungin depends on the underlying azole resistance mechanism of Aspergillus fumigatus.

artículo científico publicado en 2015

The therapeutic effect of tigecycline, unlike that of Ceftazidime, is not influenced by whether the Klebsiella pneumoniae strain produces extended-spectrum β-lactamases in experimental pneumonia in rats.

artículo científico publicado en 2012

Therapeutic drug monitoring of voriconazole and posaconazole for invasive aspergillosis.

artículo científico publicado en 2013

Therapeutic drug monitoring of voriconazole.

scientific article published on August 2008

Tigecycline Is Highly Efficacious against Mycobacterium abscessus Pulmonary Disease

artículo científico publicado en 2016

Time-kill kinetics of antibiotics active against rapidly growing mycobacteria

artículo científico publicado en 2014

Time-kill kinetics of slowly growing mycobacteria common in pulmonary disease

artículo científico publicado en 2015

Towards Rational Dosing Algorithms for Vancomycin in Neonates and Infants Based on Population Pharmacokinetic Modeling

artículo científico publicado en 2015

Typing of Pseudomonas aeruginosa strains from patients with cystic fibrosis: phenotyping versus genotyping.

artículo científico publicado en 1996

Update on antibacterial and antifungal drugs – can we master the resistance crisis? ⬇️

artículo científico publicado el 6 de septiembre de 2011

Use of a novel panel of nine short tandem repeats for exact and high-resolution fingerprinting of Aspergillus fumigatus isolates

artículo científico publicado en 2005

Which cephalosporin for gonorrhoea?

artículo científico publicado en 2004

Lista de obras de Johan Mouton

A Novel Y319H Substitution in CYP51C Associated with Azole Resistance in Aspergillus flavus.

A long journey from minimum inhibitory concentration testing to clinically predictive breakpoints: deterministic and probabilistic approaches in deriving breakpoints.

A retrospective analysis using Monte Carlo simulation to evaluate recommended ceftazidime dosing regimens in healthy volunteers, patients with cystic fibrosis, and patients in the intensive care unit

A role for TLR1, TLR2 and NOD2 in cytokine induction by Bacteroides fragilis.

A structural comparison of lipopolysaccharide biosynthesis loci of Legionella pneumophila serogroup 1 strains

Aerosol therapy in cystic fibrosis: a survey of 54 CF centers

Amikacin Pharmacokinetics/Pharmacodynamics in a Novel Hollow-Fiber Mycobacterium abscessus Disease Model

Amoxicillin pharmacokinetics in pregnant women with preterm premature rupture of the membranes

Applying pharmacokinetic/pharmacodynamic principles in critically ill patients: optimizing efficacy and reducing resistance development

Assessing in vitro combinations of antifungal drugs against yeasts and filamentous fungi: comparison of different drug interaction models.

Assessment of bactericidal drug activity and treatment outcome in a mouse tuberculosis model using a clinical Beijing strain

Assessment of efficacy of antifungals in experimental models of invasive aspergillosis in an era of emerging resistance: the value of real-time quantitative PCR.

Azole-resistant Aspergillus fumigatus, Iran.

Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink?

Chlamydia antibody testing and diagnosing tubal pathology in subfertile women: an individual patient data meta-analysis

Ciprofloxacin in preterm neonates: case report and review of the literature.

Clinical Impact of Preincubation of Blood Cultures at 37°C ⬇️

Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin

Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial

Colistin versus colistin plus meropenem for severe infections Authors' reply.

Colonization and infection by Serratia species in a paediatric surgical intensive care unit

Combination of pantothenamides with vanin inhibitors as a novel antibiotic strategy against gram-positive bacteria.

Comparison of the Etest and the sensititre colorimetric methods with the NCCLS proposed standard for antifungal susceptibility testing of Aspergillus species

Composite survival index to compare virulence changes in azole-resistant Aspergillus fumigatus clinical isolates

Conserving antibiotics for the future: New ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective ⬇️

Consistent Global Approach on Reporting of Colistin Doses to Promote Safe and Effective Use

Consumption of antimicrobials in pigs, veal calves, and broilers in the Netherlands: quantitative results of nationwide collection of data in 2011.

Continuous infusion of beta-lactams.

Correlation of MIC value and disk inhibition zone diameters in clinical Legionella pneumophila serogroup 1 isolates

Correlation of the MIC and dose/MIC ratio of fluconazole to the therapeutic response of patients with mucosal candidiasis and candidemia

Decreased ciprofloxacin susceptibility in Salmonella Typhi and Paratyphi infections in ill-returned travellers: the impact on clinical outcome and future treatment options.

Different demographic and sexual correlates for chlamydial infection and gonorrhoea in Rotterdam.

Dose-response relationships of three amphotericin B formulations in a non-neutropenic murine model of invasive aspergillosis.

EUCAST testing of Isavuconazole susceptibility in Aspergillus: comparison of results for Inoculum standardization using Conidium counting versus optical density.

Efficacy and pharmacodynamics of voriconazole combined with anidulafungin in azole-resistant invasive aspergillosis

Efficacy of antifungal therapy in a nonneutropenic murine model of zygomycosis

Exchange of Pseudomonas aeruginosa strains among cystic fibrosis siblings

Experience with a once-daily dosing program of aminoglycosides in critically ill patients

Exposure-Response Relationships for Isavuconazole in Patients with Invasive Aspergillosis and Other Filamentous Fungi.

Extensive genetic diversity within the Dutch clinical Cryptococcus neoformans population

Failure of posaconazole therapy in a renal transplant patient with invasive aspergillosis due to Aspergillus fumigatus with attenuated susceptibility to posaconazole ⬇️

Failure of the Amikacin, Cefoxitin, and Clarithromycin Combination Regimen for Treating Pulmonary Mycobacterium abscessus Infection

Forgotten antibiotics: an inventory in Europe, the United States, Canada, and Australia

Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus

Impact of pharmacodynamics on breakpoint selection for susceptibility testing

In Vitro Activity of Ceftolozane Alone and in Combination with Tazobactam against Extended-Spectrum-β-Lactamase-Harboring Enterobacteriaceae.

In Vitro Antifungal Susceptibility Testing of Candida Isolates with the EUCAST Methodology, a New Method for ECOFF Determination.

In memoriam: William A. Craig.

In vitro activities at pH 5.0 and pH 7.0 and in vivo efficacy of flucytosine against Aspergillus fumigatus.

In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates

In vitro activities of pentamidine, pyrimethamine, trimethoprim, and sulfonamides against Aspergillus species

In vitro activity of ceftazidime-avibactam combination in in vitro checkerboard assays

In vitro activity of isavuconazole against 208 Aspergillus flavus isolates in comparison with 7 other antifungal agents: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing.

In vitro interaction of voriconazole and anidulafungin against triazole-resistant Aspergillus fumigatus.

In vitro susceptibilities of zygomycetes to conventional and new antifungals

In-vitro activity of quinupristin/dalfopristin compared with other widely used antibiotics against strains isolated from patients with endocarditis ⬇️

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions

Inhibitory and fungicidal effects of antifungal drugs against Aspergillus species in the presence of serum

International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of Americ

Invasive Aspergillosis by Aspergillus flavus: Epidemiology, Diagnosis, Antifungal Resistance, and Management

Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs.

Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs.

Lung overinflation without positive end-expiratory pressure promotes bacteremia after experimental Klebsiella pneumoniae inoculation ⬇️

Molecular epidemiology of Staphylococcus aureus strains colonizing the lungs of related and unrelated cystic fibrosis patients

Moxifloxacin's Limited Efficacy in the Hollow-Fiber Model of Mycobacterium abscessus Disease

Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): a study protocol

New dosing strategies for antibacterial agents in the neonate

Optimal exposures of ceftazidime predict the probability of microbiological and clinical outcome in the treatment of nosocomial pneumonia

Oral Fosfomycin Efficacy with Variable Urinary Exposures following Single and Multiple Doses against Enterobacterales: the Importance of Heteroresistance for Growth Outcome

Oral Fosfomycin Treatment for Enterococcal Urinary Tract Infections in a Dynamic In Vitro Model

Pharmacodynamics and dose-response relationships of liposomal amphotericin B against different azole-resistant Aspergillus fumigatus isolates in a murine model of disseminated aspergillosis

Pharmacodynamics of Cefepime Combined with Tazobactam against Clinically Relevant Enterobacteriaceae in a Neutropenic Mouse Thigh Model

Pharmacodynamics of Ceftazidime and Avibactam in Neutropenic Mice with Thigh or Lung Infection

Pharmacodynamics of Ceftolozane Combined with Tazobactam against Enterobacteriaceae in a Neutropenic Mouse Thigh Model

Pharmacodynamics of Voriconazole against Wild-Type and Azole-Resistant Aspergillus flavus Isolates in a Nonneutropenic Murine Model of Disseminated Aspergillosis

Pharmacodynamics of anidulafungin against clinical Aspergillus fumigatus isolates in a nonneutropenic murine model of disseminated aspergillosis.

Pharmacodynamics of imipenem in combination with β-lactamase inhibitor MK7655 in a murine thigh model

Pharmacodynamics of isavuconazole in an Aspergillus fumigatus mouse infection model

Pharmacokinetic/pharmacodynamic modelling of antibacterials in vitro and in vivo using bacterial growth and kill kinetics: the minimum inhibitory concentration versus stationary concentration.